Boston Scientific/Guidant cross-license
This article was originally published in The Gray Sheet
Executive Summary
Cardiovascular device competitors settle all outstanding litigation regarding coronary stents, delivery systems and dilatation catheters via cross licensing agreement, announced Feb. 20. In addition to ending all suits filed by each firm, the pact helps reduce the potential for future litigation, Boston Scientific notes...